- Home
- EXEL vs XPEV Comparison
EXEL vs XPEV Comparison
Compare EXEL & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | XPEV |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | China |
| Employees | N/A | 19884 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.5B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | XPEV |
|---|---|---|
| Price | $55.65 | $12.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 5 |
| Target Price | ★ $46.50 | $23.08 |
| AVG Volume (30 Days) | 2.5M | ★ 6.2M |
| Earning Date | 05-05-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $13.61 | $25.76 |
| Revenue Next Year | $13.13 | $25.98 |
| P/E Ratio | $69.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.76 | $11.77 |
| 52 Week High | $57.57 | $28.20 |
Technical Indicators
Market Signals| Indicator | EXEL | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 42.05 |
| Support Level | $40.53 | $12.78 |
| Resistance Level | $57.57 | $14.22 |
| Average True Range (ATR) | 1.32 | 0.37 |
| MACD | -0.33 | 0.07 |
| Stochastic Oscillator | 2.45 | 9.16 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.